Josep María Cruzado Garrit

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach

Laura Martínez Valenzuela, Juliana Draibe, Xavier Fulladosa et al. · Clinical Kidney Journal · 2019 · 46 citations · Full text

Life Sciences, Immunology, Pathology +17

Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis

Laura Martínez Valenzuela, Juliana Draibe, María Quero et al. · PLoS ONE · 2018 · 29 citations · Full text

Medicine, Clinical Sciences, Nephrology +17

Results of Hepatitis C Virus Treatment in Patients on Hemodialysis: Data From Published Meta-analyses in 2008

Teresa Casanovas Taltavull, Josep María Cruzado Garrit · Transplantation Proceedings · 2009 · 13 citations

Medicine, Infectious Diseases, Nephrology +12